Cargando…
Impact of Timing following Acute Myocardial Infarction on Efficacy and Safety of Bone Marrow Stem Cells Therapy: A Network Meta-Analysis
Background. The optimal timing for Bone Marrow Stem Cells (BMCs) therapy following acute myocardial infarction (AMI) remains unclear. Aims. To synthesize the evidence from trials using a multiple-treatment comparison method, thereby permitting a broader comparison across multiple timing of BMCs ther...
Autores principales: | Liu, Bei, Duan, Chong-Yang, Luo, Cheng-Feng, Ou, Cai-Wen, Wu, Zhi-Ye, Zhang, Jian-Wu, Ni, Xiao-Bin, Chen, Ping-Yan, Chen, Min-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691493/ https://www.ncbi.nlm.nih.gov/pubmed/26783397 http://dx.doi.org/10.1155/2016/1031794 |
Ejemplares similares
-
Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction
por: Wen, Zhuzhi, et al.
Publicado: (2011) -
Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
por: Leblond, Anne-Laure, et al.
Publicado: (2009) -
Bone marrow mesenchymal stem cell-derived exosomes protect against myocardial infarction by promoting autophagy
por: Zou, Liyuan, et al.
Publicado: (2019) -
GATA-4-expressing mouse bone marrow mesenchymal stem cells improve cardiac function after myocardial infarction via secreted exosomes
por: He, Ji-Gang, et al.
Publicado: (2018) -
Bone marrow mononuclear cells and acute myocardial infarction
por: Arnous, Samer, et al.
Publicado: (2012)